Verticals / Pharma, medtech & health distribution / Grifols SA
GS
Grifols SA
grifols.com ↗—
Latest disclosed NPS
no score published
0
NPS entries
0 with a number
96%
Retention
3 Jun 2021
2021
Years covered
1 entries in all
In their words
“Customer retention rate +96% Erytra-Eflexis® Since launch on Q2 2017”
NPS disclosures (0)
No NPS disclosures yet.
Retention disclosures (1)
3 Jun 2021
Retention96%
Retention rate (Erytra-Eflexis® instruments): 96% (Since Q2 2017) — “Customer retention rate +96% Erytra-Eflexis® Since launch on Q2 2017”
— Grifols SA · SEC 6-K report · filed 3 Jun 2021 · NI-B96153C
SEC 6-K report ↗Lighthouse companies in Pharma, medtech & health distribution
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.